| First-line immunotherapy-based combinations for metastatic renal cell carcinoma: a systematic review and network meta-analysis F Quhal, K Mori, A Bruchbacher, I Resch, H Mostafaei, B Pradere, ... European Urology Oncology 4 (5), 755-765, 2021 | 137 | 2021 |
| Prevalence of female urinary incontinence in the developing world: A systematic review and meta‐analysis—A Report from the Developing World Committee of the International … H Mostafaei, H Sadeghi‐Bazargani, S Hajebrahimi, H Salehi‐Pourmehr, ... Neurourology and urodynamics 39 (4), 1063-1086, 2020 | 99 | 2020 |
| Androgen receptor signaling inhibitors in addition to docetaxel with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a systematic review and meta … T Yanagisawa, P Rajwa, C Thibault, G Gandaglia, K Mori, T Kawada, ... European urology 82 (6), 584-598, 2022 | 87 | 2022 |
| Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis K Mori, H Mostafaei, B Pradere, RS Motlagh, F Quhal, E Laukhtina, ... International journal of clinical oncology 25, 1892-1900, 2020 | 83 | 2020 |
| Diagnostic accuracy of novel urinary biomarker tests in non–muscle-invasive bladder cancer: a systematic review and network meta-analysis E Laukhtina, SR Shim, K Mori, DA David, F Soria, P Rajwa, H Mostafaei, ... European urology oncology 4 (6), 927-942, 2021 | 78 | 2021 |
| A systematic review and meta-analysis of variant histology in urothelial carcinoma of the bladder treated with radical cystectomy K Mori, M Abufaraj, H Mostafaei, F Quhal, PI Karakiewicz, A Briganti, ... The Journal of urology 204 (6), 1129-1140, 2020 | 72 | 2020 |
| The predictive value of programmed death ligand 1 in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors: a systematic review and meta-analysis K Mori, M Abufaraj, H Mostafaei, F Quhal, H Fajkovic, M Remzi, ... European Urology 79 (6), 783-792, 2021 | 62 | 2021 |
| Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis K Mori, H Mostafaei, R Sari Motlagh, B Pradere, F Quhal, E Laukhtina, ... BJU international 129 (4), 423-433, 2022 | 60 | 2022 |
| Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis K Mori, H Mostafaei, N Miura, PI Karakiewicz, S Luzzago, M Schmidinger, ... Cancer Immunology, Immunotherapy 70, 265-273, 2021 | 56 | 2021 |
| En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology T Yanagisawa, K Mori, RS Motlagh, T Kawada, H Mostafaei, F Quhal, ... The Journal of Urology 207 (4), 754-768, 2022 | 55 | 2022 |
| Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta‐analyses H Mostafaei, K Mori, S Hajebrahimi, M Abufaraj, PI Karakiewicz, ... BJU international 128 (1), 3-11, 2021 | 53 | 2021 |
| Diagnostic performance of prostate-specific membrane antigen positron emission tomography–targeted biopsy for detection of clinically significant prostate cancer: a systematic … T Kawada, T Yanagisawa, P Rajwa, RS Motlagh, H Mostafaei, F Quhal, ... European urology oncology 5 (4), 390-400, 2022 | 52 | 2022 |
| Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis K Mori, F Janisch, H Mostafaei, I Lysenko, S Kimura, S Egawa, SF Shariat Urologic Oncology: Seminars and Original Investigations 38 (5), 315-333, 2020 | 51 | 2020 |
| Penile rehabilitation strategy after nerve sparing radical prostatectomy: a systematic review and network meta-analysis of randomized trials R Sari Motlagh, M Abufaraj, L Yang, K Mori, B Pradere, E Laukhtina, ... The Journal of urology 205 (4), 1018-1030, 2021 | 50 | 2021 |
| Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis K Mori, F Janisch, MK Parizi, H Mostafaei, I Lysenko, DV Enikeev, ... International journal of clinical oncology 25, 247-257, 2020 | 47 | 2020 |
| Prognostic value of variant histology in upper tract urothelial carcinoma treated with nephroureterectomy: a systematic review and meta-analysis K Mori, F Janisch, MK Parizi, H Mostafaei, I Lysenko, S Kimura, ... The Journal of Urology 203 (6), 1075-1084, 2020 | 45 | 2020 |
| Prognostic value of lactate dehydrogenase in metastatic prostate cancer: a systematic review and meta-analysis K Mori, S Kimura, MK Parizi, DV Enikeev, PV Glybochko, V Seebacher, ... Clinical genitourinary cancer 17 (6), 409-418, 2019 | 45 | 2019 |
| Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review K Mori, N Miura, M Babjuk, PI Karakiewicz, H Mostafaei, E Laukhtina, ... Urologic Oncology: Seminars and Original Investigations 38 (10), 774-782, 2020 | 44 | 2020 |
| Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: a systematic review and meta-analysis T Yanagisawa, K Mori, T Kawada, RS Motlagh, H Mostafaei, F Quhal, ... Urologic Oncology: Seminars and Original Investigations 40 (7), 315-330, 2022 | 43 | 2022 |
| Discordance between clinical and pathological staging and grading in upper tract urothelial carcinoma K Mori, S Katayama, E Laukhtina, VM Schuettfort, B Pradere, F Quhal, ... Clinical Genitourinary Cancer 20 (1), 95. e1-95. e6, 2022 | 42 | 2022 |
Shahrokh F. Shariat, M.D.Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and GeneralAdresă de e-mail confirmată pe meduniwien.ac.at
